A Two-day Virtual Meeting

In place of our Cardiovascular Nursing Symposium canceled due to COVID-19, we are holding a two-day virtual meeting. This free interactive program will blend the latest advancements in science with practical clinical approaches to patient management.

May 20-21, 2020

In addition to 6 continuing education sessions, the virtual meeting will feature product theaters and 2 winning oral abstract presentations. Continuing education sessions include:

  • SGLT2 Inhibitors and Cardiovascular Outcomes
  • Sex Differences in Prevention and Management of Heart Failure
  • Lipid Management in 2020: Improving Patient Outcomes with Non-Statin Therapies
  • Optimal Nutrition for Cardiovascular Risk Reduction: What should we eat now?
  • Current Trends in the Diagnosis and Management of Ischemic Heart Disease and Microvascular Angina
  • Inflammation and Cardiovascular Disease: Understanding the Relationship


PCNA would like to thank the following sponsors for helping to make our program possible:

  • Amarin Pharma, Inc.
  • Amgen, Inc.
  • AstraZeneca Pharmaceuticals
  • Boehringer Ingelheim Pharmaceuticals
  • Esperion Therapeutics
  • Merck Sharp & Dohme Corp.
  • Milestone Pharmaceuticals

Questions? Contact us.

PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.